E22:  Fulvestrant in 2004: Current and future indications for breast cancer

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	65-66
Number of pages	2
Journal	European Journal of Cancer, Supplement
Volume	2
Issue number	9
DOIs	https://doi.org/10.1016/j.ejcsup.2004.08.021
Publication status	Published - 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{3e95a98c229043e082c9b061bc314d9e,

title = "E22: Fulvestrant in 2004: Current and future indications for breast cancer",

author = "A. Howell",

year = "2004",

doi = "10.1016/j.ejcsup.2004.08.021",

language = "English",

volume = "2",

pages = "65--66",

journal = "European Journal of Cancer, Supplement",

issn = "1359-6349",

publisher = "Elsevier BV",

number = "9",

}

TY - JOUR

T1 - E22

T2 - Fulvestrant in 2004: Current and future indications for breast cancer

AU - Howell, A.

PY - 2004

Y1 - 2004

UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-9744236709&partnerID=MN8TOARS

U2 - 10.1016/j.ejcsup.2004.08.021

DO - 10.1016/j.ejcsup.2004.08.021

M3 - Article

SN - 1359-6349

VL - 2

SP - 65

EP - 66

JO - European Journal of Cancer, Supplement

JF - European Journal of Cancer, Supplement

IS - 9

ER -